Impel NeuroPharma

Impel NeuroPharma is a company listed under the stock ticker IMPL (US).

View the org chart displaying its 13 main executives

Most searched biographies at Impel NeuroPharma

• Leonard Paolillo, Chief Commercial Officer, Interim President and ...
• Diane Wilfong, Director
• Darren Cline, Director

Popular executive movements at Impel NeuroPharma

• Leonard Paolillo, who was Chief Commercial Officer, is promoted to Chief Commercial Officer, Interim President and Chief Executive Officer  (posted on November 14 2023).
• Adrian Adams, Chairman and Chief Executive Officer, has left the company  (posted on November 14 2023).

Create your alert
to follow the executive moves at Impel NeuroPharma.

Impel NeuroPharma has 2,298 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• AltruBio has just announced a $225 Million fundraising (posted on May 24 2024).
• Genmab has acquired ProfoundBio (posted on May 23 2024).
• Centivo has announced the acquisition of Eden Health  (posted on May 23 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Carl Gordon - Director at Adicet Bio
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Impel NeuroPharma

• News Release Detail Impel Pharmaceuticals
• Press Releases Archives | Page 2 of 11 | Impel Neuropharma
• Press Releases Archives | Page 3 of 11 | Impel Neuropharma
• Press Releases Archives | Impel Neuropharma
• Impel News Archives | Impel Neuropharma

Social media about Impel NeuroPharma

• Impel NeuroPharma on Wikipedia, Google News & Yahoo Finance
• Impel NeuroPharma on LinkedIn, Twitter & YouTube

Contact by email its executives including Leonard Paolillo

Call Impel NeuroPharma at +1 206...

View the org chart

Register to receive your alert

Report an error